Table B.1.
FL‐no JECFA‐no | EU Register name | Structural formula | EU MSDIa US MSDI (μg/capita per day) | Classb Evaluation procedure pathc | Outcome on the named compound (d or e) | EFSA conclusion on the named compound (genotoxicity) |
---|---|---|---|---|---|---|
02.174 1617 |
2‐Methylbut‐2‐en‐1‐ol | 0.037 |
Class I A3: Intake below threshold |
d | Evaluated in FGE.201Rev2 as of no genotoxicity concern. The substance can be evaluated through the Procedure | |
05.033 1216 |
2‐Ethylhept‐2‐enal |
0.012 0.1 |
Class I A3: Intake below threshold |
d | Evaluated in FGE.201Rev2 as of no genotoxicity concern. The substance can be evaluated through the Procedure | |
05.090 1209 |
2‐Methylpent‐2‐enal |
3.4 0.2 |
Class I A3: Intake below threshold |
d | Evaluated in FGE.201Rev2 as of no genotoxicity concern. The substance can be evaluated through the Procedure | |
05.095 1201 |
2‐Methylcrotonaldehyde |
0.61 0.2 |
Class I A3: Intake below threshold |
d | Evaluated in FGE.201Rev2 as of no genotoxicity concern. The substance can be evaluated through the Procedure | |
05.105 1214 |
2‐Butylbut‐2‐enal |
0.0 0.01 |
Class I A3: Intake below threshold |
d | Evaluated in FGE.201Rev2 as of no genotoxicity concern. The substance can be evaluated through the Procedure | |
05.107 1215 |
2‐Isopropyl‐5‐methylhex‐2‐enal |
0.24 0.01 |
Class I A3: Intake below threshold |
d | Evaluated in FGE.201Rev2 as of no genotoxicity concern. The substance can be evaluated through the Procedure | |
05.126 1217 |
2‐Methyloct‐2‐enal |
0.0 7.9 |
Class I A3: Intake below threshold |
d | Evaluated in FGE.201Rev2 as of no genotoxicity concern. The substance can be evaluated through the Procedure | |
05.130 | alpha‐Sinensal | Not evaluated by JECFA | Substance not in the Register | |||
05.178 1227 |
beta‐Sinensal |
0.91 0.5 |
Class I A3: Intake below threshold |
d | Substance not supported by industry | |
07.261 | 4‐Methyl‐3‐hepten‐5‐one | – | Not evaluated by JECFA | Evaluated in FGE.201Rev2 as of no genotoxicity concern. The substance can be evaluated through the Procedure | ||
09.177 1207 |
2‐Methylallyl butyrate |
ND 0.2 |
Class I A3: Intake below threshold |
d | Substance not supported by industry | |
09.931 1226 |
2,6‐Dimethyl‐2,5,7‐octariene‐1‐ol acetate |
1.2 7.7 |
Class I A3: Intake below threshold |
d | Evaluated in FGE.207, as of no genotoxicity concern and evaluated through the Procedure in FGE.72Rev1 | |
12.065 471 |
2,8‐Dithianon‐4‐en‐4‐carboxaldehyde |
0.012 0.1 |
Class I JECFA evaluated at step B5: intake below 1.5 μg/person per day |
d | Evaluated in FGE.201Rev2 as of no genotoxicity concern. The substance can be evaluated through the Procedure | |
12.079 470 |
2‐(Methylthiomethyl)but‐2‐enal |
0.024 0.1 |
Class I JECFA evaluated at step B5: intake below 1.5 μg/person per day |
d | Evaluated in FGE.201Rev2 as of no genotoxicity concern. The substance can be evaluated through the Procedure |
ND: not determined; JECFA: The Joint FAO/WHO Expert Committee on Food Additives; FL‐no: FLAVIS number; MSDI: maximised survey‐derived daily intake; FGE: Flavouring Group Evaluation.
EU MSDI: Amount added to food as flavour in (kg/year) × 10E9/(0.1 × population in Europe (= 375 × 10E6) × 0.6 × 365) = μg/capita per day.
Thresholds of concern: Class I = 1,800 μg/person/day, Class II = 540 μg/person/day, Class III = 90 μg/person per day.
Procedure path A substances can be predicted to be metabolised to innocuous products. Procedure path B substances cannot.
No safety concern based on intake calculated by the MSDI approach of the named compound.
Data must be available on the substance or closely related substances to perform a safety evaluation.